Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 185 of 3330
Next
>>
>
4601 to 4625 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
184A1	NM	Basal	AG1024	IGF1R	RTK	0.000427	uM	5895.066	1.0313	1.0537	1.1612
184A1	NM	Basal	AG1024	IGF1R	RTK	0.00213	uM	5895.066	0.9889	0.9809	1.1612
184A1	NM	Basal	AG1024	IGF1R	RTK	0.0107	uM	5895.066	1.0087	1.0150	1.1612
184A1	NM	Basal	AG1024	IGF1R	RTK	0.0533	uM	5895.066	0.9029	0.8316	1.1612
184A1	NM	Basal	AG1024	IGF1R	RTK	0.267	uM	5895.066	0.6414	0.3643	1.1612
184A1	NM	Basal	AG1024	IGF1R	RTK	1.33	uM	5895.066	0.4503	0.0061	1.1612
184A1	NM	Basal	AG1024	IGF1R	RTK	6.67	uM	5895.066	0.3682	-0.1540	1.1612
184A1	NM	Basal	AG1024	IGF1R	RTK	33.3	uM	5895.066	0.3447	-0.2007	1.1612
184B5	NM	Basal	AG1024	IGF1R	RTK	0.0000853	uM	5896.066	0.9676	0.9543	1.4224
184B5	NM	Basal	AG1024	IGF1R	RTK	0.000427	uM	5896.066	0.9588	0.9417	1.4224
184B5	NM	Basal	AG1024	IGF1R	RTK	0.00213	uM	5896.066	0.9808	0.9729	1.4224
184B5	NM	Basal	AG1024	IGF1R	RTK	0.0107	uM	5896.066	1.0272	1.0382	1.4224
184B5	NM	Basal	AG1024	IGF1R	RTK	0.0533	uM	5896.066	1.0135	1.0189	1.4224
184B5	NM	Basal	AG1024	IGF1R	RTK	0.267	uM	5896.066	0.5022	0.2324	1.4224
184B5	NM	Basal	AG1024	IGF1R	RTK	1.33	uM	5896.066	0.4708	0.1777	1.4224
184B5	NM	Basal	AG1024	IGF1R	RTK	6.67	uM	5896.066	0.3698	-0.0062	1.4224
184B5	NM	Basal	AG1024	IGF1R	RTK	33.3	uM	5896.066	0.2954	-0.1513	1.4224
184B5	NM	Basal	AG1024	IGF1R	RTK	0.0000853	uM	5897.066	1.0366	1.0572	1.2737
184B5	NM	Basal	AG1024	IGF1R	RTK	0.000427	uM	5897.066	1.0104	1.0163	1.2737
184B5	NM	Basal	AG1024	IGF1R	RTK	0.00213	uM	5897.066	1.0310	1.0485	1.2737
184B5	NM	Basal	AG1024	IGF1R	RTK	0.0107	uM	5897.066	1.0145	1.0227	1.2737
184B5	NM	Basal	AG1024	IGF1R	RTK	0.0533	uM	5897.066	1.0277	1.0433	1.2737
184B5	NM	Basal	AG1024	IGF1R	RTK	0.267	uM	5897.066	0.5663	0.2798	1.2737
184B5	NM	Basal	AG1024	IGF1R	RTK	1.33	uM	5897.066	0.5288	0.2128	1.2737
184B5	NM	Basal	AG1024	IGF1R	RTK	6.67	uM	5897.066	0.3758	-0.0724	1.2737

|<
<<
Previous
Page 185 of 3330
Next
>>
>
4601 to 4625 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)